When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. The Quality of Life Assessment of Growth Hormone Deficiency ...

    en.wikipedia.org/wiki/The_Quality_of_Life...

    The QoL-AGHDA was published in 1999 and was funded by Pharmacia & Upjohn AB, Sweden. [4] The research company that developed the QoL-AGHDA was Galen Research. [5] The measure was originally created for use in UK English, Swedish, Italian, German and Spanish, but later on it was also adapted for the United States, Belgium, the Netherlands, Brazil and Denmark.

  3. ACTH stimulation test - Wikipedia

    en.wikipedia.org/wiki/ACTH_stimulation_test

    The ACTH test (also called the cosyntropin, tetracosactide, or Synacthen test) is a medical test usually requested and interpreted by endocrinologists to assess the functioning of the adrenal glands' stress response by measuring the adrenal response to adrenocorticotropic hormone (ACTH; corticotropin) or another corticotropic agent such as tetracosactide (cosyntropin, tetracosactrin; Synacthen ...

  4. Growth hormone therapy - Wikipedia

    en.wikipedia.org/wiki/Growth_hormone_therapy

    Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical ...

  5. Growth hormone deficiency - Wikipedia

    en.wikipedia.org/wiki/Growth_hormone_deficiency

    Diagnosis involves blood tests to measure growth hormone levels. [2] Treatment is by growth hormone replacement using synthetic human growth hormone. [1] The frequency of the condition is unclear. [2] Most cases are initially noticed in children. [1] The genetic forms of this disease are estimated to affect about 1 in 7,000 people. [3]

  6. Isolated growth hormone deficiency - Wikipedia

    en.wikipedia.org/wiki/Isolated_growth_hormone...

    The diagnosis of growth hormone deficiency is a multi-step procedure that involves pituitary MRI, biochemical testing (growth hormone stimulation tests and measurement of IGF-1/IGFBP3), clinical and auxological examination, and genetic test results. [8]

  7. Maternal physiological changes in pregnancy - Wikipedia

    en.wikipedia.org/wiki/Maternal_physiological...

    Hormone Test Result FSH, LH: GnRH stimulation: Unresponsive from third gestation until several weeks postpartum Growth Hormone: Insulin tolerance test: Response increases during first half of pregnancy and then normalizes until several weeks postpartum TSH: TRH stimulation: Response unchanged Pancreatic Insulin: Glucose tolerance test

  8. Hypothalamic–pituitary–somatotropic axis - Wikipedia

    en.wikipedia.org/wiki/Hypothalamic–pituitary...

    The hypothalamic–pituitary–somatotropic axis (HPS axis), or hypothalamic–pituitary–somatic axis, also known as the hypothalamic–pituitary–growth axis, is a hypothalamic–pituitary axis which includes the secretion of growth hormone (GH; somatotropin) from the somatotropes of the pituitary gland into the circulation and the subsequent stimulation of insulin-like growth factor 1 ...

  9. Growth hormone–releasing hormone - Wikipedia

    en.wikipedia.org/wiki/Growth_hormone–releasing...

    Growth hormone–releasing hormone (GHRH), also known as somatocrinin among other names in its endogenous form and as somatorelin in its pharmaceutical form, is a releasing hormone of growth hormone (GH). It is a 44 [1]-amino acid peptide hormone produced in the arcuate nucleus of the hypothalamus.